Editorial: The pharmacogenomics of human growth

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 795-796

  Rosenfeld, Ron G ^a,b,c  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; JANUS KINASE 2; SOMATOMEDIN; SOMATOMEDIN C;

BODY HEIGHT; DWARFISM; EDITORIAL; EXON; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GIGANTISM; GROWTH; GROWTH HORMONE DEFICIENCY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; NONHUMAN; NONSENSE MUTATION; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT STATURE; TREATMENT INDICATION; TREATMENT OUTCOME;

BODY HEIGHT; CHILD; FEMALE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MALE;

EID: 33644827060     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0026     Document Type: Editorial

References (14)

1. Reiter EO, Rosenfeld RG 2003 Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology, 10th ed. Philadelphia: Saunders; 1003-1114
2. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A, on behalf of The Genentech Growth Study Group 1997 Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab 82:418-420
3. Carel JC, Ecosse E, Nicolino M, Tauber M, Leger J, Cabrol S, Bastie-Sigeac I, Chaussain JL, Coste J 2002 Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry. BMJ 325:70
4. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, on behalf of the KIGS International Board 1999 Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. J Clin Endocrinol Metab 84:1174-1183
5. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor I in mouse postnatal growth. Dev Biol 229:141-162
6. Rosenfeld RG 2005 The molecular basis of idiopathic short stature. Growth Horm IGF Res 15:S3-S5
7. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG 2003 Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349:1139-1147
8. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goosens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
9. Sobrier ML, Duquesnoy P, Duriez B, Amselem S, Goosens M 1993 Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319:16-20
10. Pantel J, Grulich-Henn J, Bettendorf M, Strasburger CJ, Heinrich U, Amselem S 2003 Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron Syndrome) and the issue of the origin and function of the GHRd3 isoform. J Clin Endocrinol Metab 88:1705-1710
11. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
12. Jorge AAL, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJP 2006 Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076-1080
13. Rosenfeld RG, Buckway C, Selva K, Pratt KL, Guevara-Aguirre J 2004 Insulin-like growth factor (IGF) parameters and tools for efficacy: the IGF-I generation test in children. Horm Res 62(Suppl 1):37-43
14. Cohen P, Rogol A, Howard C, Kappelgaard A-M, Rosenfeld R 2005 IGF-based dosing of growth hormone accelerates the growth velocity of children with growth hormone deficiency (GHD) and idiopathic short stature. Horm Res 64(Suppl 1):48